Board of Directors

IR Nav

Dean Petkanas

Chairman & CEO [-]

Dean Petkanas is a corporate finance and executive management professional with over 25 years of investment banking and capital markets experience.

In 2010 Mr. Petkanas co-founded Kannalife Sciences, Inc. and for the past 8 years was principally responsible for the creation and execution of the Companys business model, including the licensing of US Patent #6630507 from the National Institutes of Health for disease indications Hepatic Encephalopathy (HE) and Chronic Traumatic Encephalopathy (CTE). In 2013, he was responsible for securing Series A financing for Kannalife.

Mr. Petkanas is a co-inventor of US Patent #9611213 Novel Functionalized 1,3 Benzene Diols and Their Method of Use for the Treatment of Hepatic Encephalopathy

Mr. Petkanas background in pharmaceutical extends to his work as investment banker and subsequently V.P. of Business Development for Xechem International, Inc. where he was principally responsible for Xechems IPO and EXIM Bank rounds of financing. Mr. Petkanas was involved with Xechem from 1992 to 2007. While at Xechem, he was involved in the financing of Xechems lead target drug candidate (generic paclitaxel) and later on from 2003 to 2007, was the the lead petitioner for Xechem International in steering their federal anti-trust lawsuit against Bristol-Myers-Squibb for their illegal monopoly of the drug market for the anti-cancer drug, Taxol. Mr. Petkanas also was an integral part of the development team that named, trademarked and commercialized Hemoxin (Nicosan), a phyto-pharmaceutical compound for the treatment of Sickle Cell disease.

Thoma Kikis

Founder / Chief Communications Officer, Board Director [-]

Thoma Kikis is an entrepreneur, media and entertainment executive for over 17 years. For the past 8 years Mr. Kikis has been building Kannalife Sciences with the CEO and instrumental in the companys branding and communications.

Prior to co-founding Kannalife, Mr. Kikis executive produced the comedy film Its a Disaster, starring Julia Stiles, David Cross and America Ferrera and co-produced the award winning film Alps by the innovative Oscar nominated director Yorgos Lanthimos. He was a co-founder and Executive Vice President of Ovie Entertainment. He previously produced Darkon, a real-life role play documentary about fictional action characters similar to a real life game of Dungeons and Dragons. Darkon was purchased for remake by Brad Pitts Plan B and Paramount Pictures and the documentary was distributed by IFC.

Previously he has also worked with Viacom, MTV Interactive, redesigned, The Alexander S. Onassis Public Benefit Foundation, Empire Blue Cross/Blue Shield, Icon Medialab, Teachers College, Columbia University, and TCI/Teachers College Innovations among others.

Mr. Kikis was compelled by his father (who suffered with Hepatic Encephalopathy) and cousin Dr. Steven Kazianis PhD, (who suffered and died of Brain Cancer) to find treatments for neurodegenerative related diseases and has made it his lifes goal in finding treatments for diseases that effect the brain.

Mr. Kikis hold a Bachelor of Science in Communications Management from New York University.

Robert Malasek

Board Director [-]

Mr. Malaseks experience includes serving as the Assistant Controller for Starwood Hotel & Resorts Worldwide, Inc. and as Chief Financial Officer for NatureWell, Inc. From 2011 to 2015, Mr. Malasek served as the Chief Financial Officer, Secretary, Treasurer and a Director of Liberty Coal Energy Corp. Since 2015, Mr. Malasek has served as the Chief Financial Officer of Cannalink, Inc. and currently serves as the Chief Financial Officer of AXIM Biotechnologies, Inc. (OTC:AXIM). Mr. Malasek received his Bachelor of Science in Accountancy from San Diego State University. Mr. Malaseks public company governance and management experience make him a great fit to the board of directors.

Blake Schroeder

Board Director [-]

Mr. Schroeders career began as a litigator at a commercial litigation firm in Salt Lake City, UT. Beginning in 2008, Schroeder became involved in the sale and marketing of natural products, and opening international marketplaces to those products. From 2008 to 2015 Mr. Schroeder served in various capacities at MonaVie LLC developing international business plans and growing international businesses. From August 2014 to February 2016, Mr. Schroeder served as the chief operating officer of Forevergreen International, where he was responsible for global operation and sales of the multinational organization, including oversight of a global supply chain. From 2016 to the present, Mr. Schroeder serves as the chief executive officer of Kannaway, LLC, a wholly-owned subsidiary of Medical Marijuana, Inc. Mr. Schroeder is the COO for Medical Marijuana, Inc. and has served on the board of directors of Medical Marijuana, Inc. from March 2016 to the present. Mr. Schroeder holds a B.S. in Finance from Utah State University and a J.D. from Syracuse Universitys College of Law. Mr. Schroeders blend of industry, legal and business knowledge give him and the board of directors a unique viewpoint that is invaluable to the board of directors.

Timothy Scott, PhD

Board Director [-]

Dr. Scott brings years of enterprise board-level management expertise having served on the board of directors of NatureWell Inc. from 2001-2008. Prior to 2001, Dr. Scott served on the board of directors of ICH Corporation, which owned 265 restaurants with approximately $265M in revenues and 7,800 employees. Dr. Scott currently serves on the board of directors of Medical Marijuana, Inc. (OTC:MJNA) and Axim Biotechnologies, Inc. (OTC:AXIM). Dr. Scott received his Ph.D. in theology from Christian University. Dr. Scott holds decades of experience at senior management and board levels in public and private companies which is a great benefit to the company and its board of directors.